| [1] PubMed ID: | 31064820 |
| Disease Name: | Non-alcoholic Fatty Liver Disease |
| Sample: | liver tissues,cell lines |
| Dysfunction Pattern: | Regulation[miR-130a/PPARγ axis] |
| Validated Method: | RNA Pull-Down//Western Blot//qRT-PCR//Luciferase Report Assay//Oil Red O Staining//ELISA//IHC |
| Description: | H19 and PPARγ were up-regulated, while miR-130a was down-regulated in NAFLD mouse and cellular model.Knockdown of H19 inhibited steatosis and TG secretion in FFA-induced hepatocytes. H19 could bind to miR-130a, and miR-130a could directly inhibit PPARγ expression. Meanwhile, miR-130a inhibited lipid accumulation by down-regulating NAFLD-related genes PPARγ, SREBP1, SCD1, ACC1 and FASN. Overexpression of miR-130a and PPARγ antagonist GW9662 inhibited lipogenesis and TG secretion, and PPARγ agonist GW1929 reversed this change induced by miR-130a up-regulation. |
| Causality: | No |
| Causal Description: | |
| Clinical-realted Application: | |
|